User profiles for Fanfan Zhou
Fanfan Zhou悉尼大学 Verified email at sydney.edu.au Cited by 3276 |
[HTML][HTML] Long COVID in a prospective cohort of home-isolated patients
Long-term complications after coronavirus disease 2019 (COVID-19) are common in hospitalized
patients, but the spectrum of symptoms in milder cases needs further investigation. We …
patients, but the spectrum of symptoms in milder cases needs further investigation. We …
[HTML][HTML] Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort …
…, L Wang, S Niu, Z Yao, X Deng, F Zhou… - The Lancet …, 2020 - thelancet.com
Background COVID-19 has spread globally. Epidemiological susceptibility to COVID-19 has
been reported in patients with cancer. We aimed to systematically characterise clinical …
been reported in patients with cancer. We aimed to systematically characterise clinical …
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene …
…, W Ai, M Ponzoni, AJM Ferreri, F Zhou… - Blood, The Journal …, 2013 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal
center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on gene …
center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on gene …
[PDF][PDF] A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects
J Zhang, Q Lian, G Zhu, F Zhou, L Sui, C Tan… - Cell stem cell, 2011 - cell.com
The segmental premature aging disease Hutchinson-Gilford Progeria syndrome (HGPS) is
caused by a truncated and farnesylated form of Lamin A called progerin. HGPS affects …
caused by a truncated and farnesylated form of Lamin A called progerin. HGPS affects …
Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF‐7 cells
Gallic acid (GA), a polyhydroxylphenolic compound abundantly distributed in plants, fruits,
and foods, has been reported to have various biological activities including an anticancer …
and foods, has been reported to have various biological activities including an anticancer …
[HTML][HTML] Role of glycosylation in the organic anion transporter OAT1
K Tanaka, W Xu, F Zhou, G You - Journal of Biological Chemistry, 2004 - ASBMB
Organic anion transporters (OAT) play essential roles in the body disposition of clinically
important anionic drugs, including antiviral drugs, antitumor drugs, antibiotics, antihypertensives…
important anionic drugs, including antiviral drugs, antitumor drugs, antibiotics, antihypertensives…
Protective Effect of Paeoniflorin on Aβ25–35-Induced SH-SY5Y Cell Injury by Preventing Mitochondrial Dysfunction
Alzheimer’s disease (AD) is a major neurodegenerative brain disorder affecting about 14
million people worldwide. Aβ-induced cell injury is a crucial cause of neuronal loss in AD, thus …
million people worldwide. Aβ-induced cell injury is a crucial cause of neuronal loss in AD, thus …
The role of N-linked glycosylation in protein folding, membrane targeting, and substrate binding of human organic anion transporter hOAT4
We used a novel approach to evaluate how the addition/acquisition and processing/modification
of N-linked oligosaccharides play a role in the functional maturation of human organic …
of N-linked oligosaccharides play a role in the functional maturation of human organic …
Chloroquine and hydroxychloroquine are novel inhibitors of human organic anion transporting polypeptide 1A2
Chloroquine (CQ) and hydroxychloroquine (HCQ) are widely used to treat malaria and
inflammatory diseases, long-term usage of which often causes severe side effects, especially …
inflammatory diseases, long-term usage of which often causes severe side effects, especially …
Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases
The delivery of cures for retinal diseases remains problematic. There are four main challenges:
passing through multiple barriers of the eye, the delivery to particular retinal cell types, …
passing through multiple barriers of the eye, the delivery to particular retinal cell types, …